Notice of Meeting for the Interdepartmental Serious Mental Illness Coordinating Committee, 3427-3428 [2023-00916]
Download as PDF
Federal Register / Vol. 88, No. 12 / Thursday, January 19, 2023 / Notices
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; NIEHS Research Intensive
Short Courses and Educational
Opportunities.
Date: April 6, 2023.
Time: 1:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Environmental
Health Sciences, Keystone Building, 530
Davis Drive, Durham, NC 27709 (Virtual
Meeting).
Contact Person: Beverly W. Duncan, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, National Institute of Environmental
Health Sciences, Research Triangle Park, NC
27709, (240) 353–6598, beverly.duncan@
nih.gov.
Name of Committee: National Institute of
Environmental Health Sciences Special
Emphasis Panel; NIEHS Genetic Diversity in
Toxicity Testing: New Approaches in
Determining Response Variability From
Environmental Exposures.
Date: April 11, 2023.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Environmental
Health Sciences, Keystone Building, 530
Davis Drive, Durham, NC 27709 (Virtual
Meeting).
Contact Person: Leroy Worth, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research and
Training, National Institute of Environmental
Health Science, Research Triangle Park, NC
27709, (984) 287–3340, worth@niehs.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.115, Biometry and Risk
Estimation—Health Risks from
Environmental Exposures; 93.142, NIEHS
Hazardous Waste Worker Health and Safety
Training; 93.143, NIEHS Superfund
Hazardous Substances—Basic Research and
Education; 93.894, Resources and Manpower
Development in the Environmental Health
Sciences; 93.113, Biological Response to
Environmental Health Hazards; 93.114,
Applied Toxicological Research and Testing,
National Institutes of Health, HHS)
Dated: January 12, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–00920 Filed 1–18–23; 8:45 am]
BILLING CODE 4140–01–P
khammond on DSKJM1Z7X2PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Notice of Meeting for the
Interdepartmental Serious Mental
Illness Coordinating Committee
Substance Abuse and Mental
Health Services Administration,
AGENCY:
VerDate Sep<11>2014
17:49 Jan 18, 2023
Jkt 259001
Department of Health and Human
Services.
ACTION: Notice.
The Secretary of Health and
Human Services announces a meeting of
the Interdepartmental Serious Mental
Illness Coordinating Committee
(ISMICC).
The meeting will provide information
on federal efforts related to serious
mental illness (SMI) and serious
emotional disturbance (SED).
DATES: March 14, 2023, 11 a.m. to 4 p.m.
(EDT)/Open.
ADDRESSES: The meeting is open to the
public and can be accessed virtually
only by accessing: https://
www.zoomgov.com/j/
1610294627?pwd=V1FTTEtKRmx
ORktqNndHMDZhelhxUT09, or by
dialing 646–828–7666, webinar ID: 161
029 4627, passcode: 127155. Agenda
with call-in information will be posted
on the SAMHSA website prior to the
meeting at https://www.samhsa.gov/
about-us/advisory-councils/meetings.
FOR FURTHER INFORMATION CONTACT:
Pamela Foote, ISMICC Designated
Federal Officer, SAMHSA, 5600 Fishers
Lane, 14E53C, Rockville, MD 20857;
telephone: 240–276–1279; email:
pamela.foote@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background and Authority
The ISMICC was established on
March 15, 2017, in accordance with
section 6031 of the 21st Century Cures
Act, and the Federal Advisory
Committee Act, 5 U.S.C. App., as
amended, to report to the Secretary,
Congress, and any other relevant federal
department or agency on advances in
SMI and SED, research related to the
prevention of, diagnosis of, intervention
in, and treatment and recovery of SMIs,
SEDs, and advances in access to services
and supports for adults with SMI or
children with SED. In addition, the
ISMICC will evaluate the effect federal
programs related to SMI and SED have
on public health, including public
health outcomes such as: (A) rates of
suicide, suicide attempts, incidence and
prevalence of SMIs, SEDs, and
substance use disorders, overdose,
overdose deaths, emergency
hospitalizations, emergency room
boarding, preventable emergency room
visits, interaction with the criminal
justice system, homelessness, and
unemployment; (B) increased rates of
employment and enrollment in
educational and vocational programs;
(C) quality of mental and substance use
disorders treatment services; or (D) any
other criteria determined by the
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
3427
Secretary. Finally, the ISMICC will
make specific recommendations for
actions that agencies can take to better
coordinate the administration of mental
health services for adults with SMI or
children with SED. Not later than one
(1) year after the date of enactment of
the 21st Century Cures Act, and five (5)
years after such date of enactment, the
ISMICC shall submit a report to
Congress and any other relevant federal
department or agency.
II. Membership
This ISMICC consists of federal
members listed below or their
designees, and non-federal public
members.
Federal Membership: Members
include, The Secretary of Health and
Human Services; The Assistant
Secretary for Mental Health and
Substance Use; The Attorney General;
The Secretary of the Department of
Veterans Affairs; The Secretary of the
Department of Defense; The Secretary of
the Department of Housing and Urban
Development; The Secretary of the
Department of Education; The Secretary
of the Department of Labor; The
Administrator of the Centers for
Medicare and Medicaid Services; the
Administrator of the Administration for
Community Living, and The
Commissioner of the Social Security
Administration.
Non-federal Membership: Members
include, not less than 14 non-federal
public members appointed by the
Secretary, representing psychologists,
psychiatrists, social workers, peer
support specialists, and other providers,
patients, family of patients, law
enforcement, the judiciary, and leading
research, advocacy, or service
organizations.
The ISMICC is required to meet at
least twice per year.
To attend virtually, submit written or
brief oral comments, or request special
accommodation for persons with
disabilities, contact Pamela Foote.
Individuals can also register at https://
snacregister.samhsa.gov/.
The public comment section will be
scheduled at the conclusion of the
meeting. Individuals interested in
submitting a comment, must notify
Pamela Foote on or before February 21,
2023, via email to: Pamela.Foote@
samhsa.hhs.gov.
Up to three minutes will be allotted
for each approved public comment as
time permits. Written comments
received in advance of the meeting will
be considered for inclusion in the
official record of the meeting.
Substantive meeting information and
a roster of Committee members is
E:\FR\FM\19JAN1.SGM
19JAN1
3428
Federal Register / Vol. 88, No. 12 / Thursday, January 19, 2023 / Notices
available at the Committee’s website:
https://www.samhsa.gov/about-us/
advisory-councils/ismicc.
Dated: January 12, 2023.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2023–00916 Filed 1–18–23; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Meeting
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Prevention’s
(CSAP) Drug Testing Advisory Board
(DTAB) will convene via web
conference on March 7, 2023, from 10
a.m. EST to 4:30 p.m. EST.
The board will meet in open-session
March 7, 2023, from 10 a.m. EST to 2
p.m. EST to discuss the Mandatory
Guidelines for Federal Workplace Drug
Testing Programs, updates to the
Electronic Chain of Custody Form
(ECCF), as well as updates from the
Department of Transportation, the
Nuclear Regulatory Commission, the
Department of Defense, and the Food
and Drug Administration as well as a
presentation by Dr. Svante Vikingsson
on Fentanyl and Opioids Pulse Study
results.
The board will meet in closed session
on March 7, 2023, from 2:15 p.m. EST
to 4:30 p.m. EST to discuss issues
surrounding cannabinoids pertaining to
the effect of the proliferation of various
cannabinoid isomers, including Delta–
8–THC, on federal workplace drug
testing programs, including federal and
state responses to cannabinoid drug
testing issues of concern, and potential
SAMSHA actions. In closed session the
board will also review information and
proposed actions concerning the
Department of Health and Humans
Services (HHS) Mandatory Guideline
internal review and approval process
that has not been made public by HHS.
Therefore, the March 7, 2023, meeting
from 2:15 p.m. to 4:30 p.m. is closed to
the public, as determined by the
Assistant Secretary for Mental Health
and Substance Use, SAMHSA, in
accordance with 5 U.S.C. 552b(c)(9)(B)
and 5 U.S.C. App. 2, section 10(d).
Meeting registration information can
be completed at https://
snacregister.samhsa.gov/. Web
conference and call information will be
VerDate Sep<11>2014
17:49 Jan 18, 2023
Jkt 259001
sent after completing registration.
Meeting information and a roster of
DTAB members may be obtained by
accessing the SAMHSA Advisory
Committees website, https://
www.samhsa.gov/about-us/advisorycouncils/meetings, or by contacting the
Designated Federal Officer, Lisa Davis.
Committee Name: Substance Abuse
and Mental Health Services
Administration, Center for Substance
Abuse Prevention, Drug Testing
Advisory Board.
Dates/Time/Type: March 7, 2023,
from 10 a.m. EST to 2 p.m. EST: OPEN;
March 7, 2023, from 2:15 p.m. EST to
4:30 p.m. EST: CLOSED.
Place: Substance Abuse and Mental
Health Services Administration, 5600
Fishers Lane, Rockville, MD 20857.
Contact: Lisa S. Davis, M.S., Social
Science Analyst, Center for Substance
Abuse Prevention, 5600 Fishers Lane,
Rockville, Maryland 20857, Telephone:
(240) 276–1440, Email: Lisa.Davis@
samhsa.hhs.gov.
Anastasia Marie Donovan,
Public Health Advisor, Division of Workplace
Programs.
[FR Doc. 2023–00911 Filed 1–18–23; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[FWS–R1–ES–2022–0169; ES11140100000–
234–FF01E0000]
Candidate Conservation Agreement
With Assurances for the Fisher in
Oregon; Enhancement of Survival
Permit Applications; Hampton and
Starker Site Plans
Fish and Wildlife Service,
Interior.
ACTION: Notice of availability; request
for comments.
AGENCY:
We, the U.S. Fish and
Wildlife Service (Service), received two
enhancement of survival permit (permit)
applications pursuant to the Endangered
Species Act (ESA). If granted, the
requested permits would authorize take
of the fisher (Pekania pennanti),
incidental to otherwise lawful activities,
if the species becomes federally listed
under the ESA. These applications are
associated with a template candidate
conservation agreement with assurances
(CCAA) developed by the Service for the
conservation of the fisher. We have also
prepared draft environmental action
statements documenting our
preliminary determination that the
permit decisions may be eligible for
SUMMARY:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
categorical exclusion under the National
Environmental Policy Act. We provide
this notice to open a public comment
period and invite comments from all
interested parties.
DATES: Submit written comments no
later than February 21, 2023.
ADDRESSES:
Obtaining Documents: The
applications, application supporting
materials, and any comments and other
materials that we receive will be
available for public inspection at
https://www.regulations.gov in Docket
No. FWS–R1–ES–2022–0169.
Submitting Comments: To submit
written comments, please use one of the
following methods:
• Internet: https://
www.regulations.gov. Search for and
submit comments on Docket No. FWS–
R1–2022–0169.
• U.S. Mail: Attn: Docket No. FWS–
R1–ES–2022–0169; U.S. Fish and
Wildlife Service Headquarters, MS:
PRB/3W; 5275 Leesburg Pike, Falls
Church, VA 22041–3803.
For more information, see Public
Availability of Comments under
SUPPLEMENTARY INFORMATION.
FOR FURTHER INFORMATION CONTACT:
Frank Weaver, via telephone at 541–
957–3471, or via email at Frank_
Weaver@fws.gov. Individuals in the
United States who are deaf, deafblind,
hard of hearing, or have a speech
disability may dial 711 (TTY, TDD, or
TeleBraille) to access
telecommunications relay services.
Individuals outside the United States
should use the relay services offered
within their country to make
international calls to the point-ofcontact in the United States.
SUPPLEMENTARY INFORMATION: We, the
U.S. Fish and Wildlife Service (Service),
have received two enhancement of
survival permit (permit) applications
pursuant to section 10(a)1(A) of the
Endangered Species Act of 1973, as
amended (ESA; 16 U.S.C. 1531 et seq.).
The two applicants are Hampton
Lumber (Hampton) and Starker Forest
Inc./Starker Properties LLC (Starker).
If granted, either or both of the
requested permits would authorize take
of the fisher (Pekania pennanti)
incidental to the applicants’ routine
forest-related management activities, if
the species becomes federally listed
under the ESA. Each application
includes a proposed individual site plan
developed under a template candidate
conservation agreement with assurances
(CCAA) developed by the Service in
2018 for the conservation of the fisher.
The conservation measures in the CCAA
are intended to provide a net
E:\FR\FM\19JAN1.SGM
19JAN1
Agencies
[Federal Register Volume 88, Number 12 (Thursday, January 19, 2023)]
[Notices]
[Pages 3427-3428]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00916]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Notice of Meeting for the Interdepartmental Serious Mental
Illness Coordinating Committee
AGENCY: Substance Abuse and Mental Health Services Administration,
Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Secretary of Health and Human Services announces a meeting
of the Interdepartmental Serious Mental Illness Coordinating Committee
(ISMICC).
The meeting will provide information on federal efforts related to
serious mental illness (SMI) and serious emotional disturbance (SED).
DATES: March 14, 2023, 11 a.m. to 4 p.m. (EDT)/Open.
ADDRESSES: The meeting is open to the public and can be accessed
virtually only by accessing: https://www.zoomgov.com/j/1610294627?pwd=V1FTTEtKRmxORktqNndHMDZhelhxUT09, or by dialing 646-828-
7666, webinar ID: 161 029 4627, passcode: 127155. Agenda with call-in
information will be posted on the SAMHSA website prior to the meeting
at https://www.samhsa.gov/about-us/advisory-councils/meetings.
FOR FURTHER INFORMATION CONTACT: Pamela Foote, ISMICC Designated
Federal Officer, SAMHSA, 5600 Fishers Lane, 14E53C, Rockville, MD
20857; telephone: 240-276-1279; email: [email protected].
SUPPLEMENTARY INFORMATION:
I. Background and Authority
The ISMICC was established on March 15, 2017, in accordance with
section 6031 of the 21st Century Cures Act, and the Federal Advisory
Committee Act, 5 U.S.C. App., as amended, to report to the Secretary,
Congress, and any other relevant federal department or agency on
advances in SMI and SED, research related to the prevention of,
diagnosis of, intervention in, and treatment and recovery of SMIs,
SEDs, and advances in access to services and supports for adults with
SMI or children with SED. In addition, the ISMICC will evaluate the
effect federal programs related to SMI and SED have on public health,
including public health outcomes such as: (A) rates of suicide, suicide
attempts, incidence and prevalence of SMIs, SEDs, and substance use
disorders, overdose, overdose deaths, emergency hospitalizations,
emergency room boarding, preventable emergency room visits, interaction
with the criminal justice system, homelessness, and unemployment; (B)
increased rates of employment and enrollment in educational and
vocational programs; (C) quality of mental and substance use disorders
treatment services; or (D) any other criteria determined by the
Secretary. Finally, the ISMICC will make specific recommendations for
actions that agencies can take to better coordinate the administration
of mental health services for adults with SMI or children with SED. Not
later than one (1) year after the date of enactment of the 21st Century
Cures Act, and five (5) years after such date of enactment, the ISMICC
shall submit a report to Congress and any other relevant federal
department or agency.
II. Membership
This ISMICC consists of federal members listed below or their
designees, and non-federal public members.
Federal Membership: Members include, The Secretary of Health and
Human Services; The Assistant Secretary for Mental Health and Substance
Use; The Attorney General; The Secretary of the Department of Veterans
Affairs; The Secretary of the Department of Defense; The Secretary of
the Department of Housing and Urban Development; The Secretary of the
Department of Education; The Secretary of the Department of Labor; The
Administrator of the Centers for Medicare and Medicaid Services; the
Administrator of the Administration for Community Living, and The
Commissioner of the Social Security Administration.
Non-federal Membership: Members include, not less than 14 non-
federal public members appointed by the Secretary, representing
psychologists, psychiatrists, social workers, peer support specialists,
and other providers, patients, family of patients, law enforcement, the
judiciary, and leading research, advocacy, or service organizations.
The ISMICC is required to meet at least twice per year.
To attend virtually, submit written or brief oral comments, or
request special accommodation for persons with disabilities, contact
Pamela Foote. Individuals can also register at https://snacregister.samhsa.gov/.
The public comment section will be scheduled at the conclusion of
the meeting. Individuals interested in submitting a comment, must
notify Pamela Foote on or before February 21, 2023, via email to:
[email protected]
Up to three minutes will be allotted for each approved public
comment as time permits. Written comments received in advance of the
meeting will be considered for inclusion in the official record of the
meeting.
Substantive meeting information and a roster of Committee members
is
[[Page 3428]]
available at the Committee's website: https://www.samhsa.gov/about-us/advisory-councils/ismicc.
Dated: January 12, 2023.
Carlos Castillo,
Committee Management Officer.
[FR Doc. 2023-00916 Filed 1-18-23; 8:45 am]
BILLING CODE 4162-20-P